Clinical Study Demonstrates Promising Results for Investigative ALS Treatment; InFlectis BioScience is Planning Phase 2 Trial of Next-Generation Therapy
Clinical Study Demonstrates Promising Results for Investigative ALS Treatment; InFlectis BioScience is Planning Phase 2 Trial of Next-Generation Therapy Reportable 30 Apr 2021, 01:16 GMT+10 Clinical Study Demonstrates Promising Results for Investigative ALS Treatment; InFlectis BioScience is Planning Phase 2 Trial of Next-Generation Therapy Milan, Italy, & Nantes, France -- April 29, 2021 -- A new study shows indications that Amyotrophic Lateral Sclerosis (ALS) may be treated with small molecul...
Pierre Miniou Francina Agosti Reportable Inc Clinical Study Demonstrates Promising Results Inflectis Bioscience Planning Phase
Source: parisguardian.com